Table 2.
Variable | Unadjusted |
P
Value |
Adjusted |
P
Value |
Contemporaneous Sensitivity Cohort |
P
Value |
---|---|---|---|---|---|---|
COVID-19 patient | 1.4 (1.1–1.9) | .02 | 1.4 (1.0–1.9) | .046 | 2.4 (1.2–4.5) | .01 |
AGP (n=321) | 0.9 (0.6–1.2) | .39 | 0.9 0.6–1.2) | .44 | 1.0 (0.5–2.2) | .97 |
Non-AGP (n=634) | 1.5 (1.1–2.0) | .009 | 1.4 (1.04–1.9) | .03 | 2.2 (1.2–4.1) | .01 |
COVID PUI | 0.9 (0.7–1.3) | .64 | 0.9 (0.6–1.2) | .36 | 2.5 (1.0–6.1) | .04 |
AGP (n=288) | 0.8 (0.5–1.1) | .09 | 0.8 (0.5–1.1) | .12 | 0.7 (0.3–1.4) | .31 |
Non-AGP (n=759) | 1.0 (0.8–1.4) | .86 | 1.0 (0.7–1.3) | .76 | 2.1 (0.98–4.5) | .06 |
Non-COVID patient | 0.7 (0.5–1.0) | .06 | 0.8 (0.6–1.1) | .22 | 0.5 (0.2–0.9) | .02 |
Sick colleague (n=459)a | 4.9 (3.6–6.6) | <.001 | 4.4 (3.2–6.0) | <.001 | 4.8 (2.5–9.2) | <.01 |
Note. AGP, aerosol-generating procedure; PUI, person under investigation for COVID-19.
COVID symptoms or diagnosed with confirmed COVID-19.